Responses on the IWQOL-Lite-CT physical function score were reported as confirmatory secondary outcomes in the STEP 1 and STEP 2 studies
They claim to support metabolism, energy, appetite control, and overall wellness
A., & Darabi, M
On average, participants lost 7.8% to 12.4% of their body weight, and 40% of people on the highest dose lost more than 15%, Eli Lilly reported
Additionally, the severity and persistence of hiccups appear to vary widely among patients, indicating that individual physiological differences may play a role in susceptibility to this side effect
The study found that GLP-1 receptor agonists may have antidepressant-like effects in animal models, suggesting potential therapeutic applications for mood disorders in humans (Egefjord et al., 2018)